Recent evidence shows that VEGF constitutes an exhaled biomarker in IPF, with significant correlations with the clinical manifestations [55], and patients with idiopathic interstitial pneumonia have higher VEGF levels in plasma [56]. Here, VEGFA is linked to idiopathic pulmonary fibrosis.